http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110128472-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-822
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-249
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C29-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
filingDate 2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110128472-B
titleOfInvention Synthesis and application of an oxaspirocyclic PNN-type ligand
abstract The patent of the present invention belongs to the field of chiral synthesis, and specifically provides the synthesis of a new type of oxaspirocyclic PNN ligand. The ligand starts from oxaspirocyclic diphenol and undergoes trifluoromethanesulfonylation, palladium-catalyzed coupling of diarylphosphine oxide, trichlorosilylation reduction, palladium-catalyzed carbonyl esterification, hydrolysis, amination, and reductive amination and other steps to synthesize. The oxaspiro compound has central chirality. Therefore, there are left-handed oxaspiro PNN ligands and right-handed oxaspiro PNN ligands. The racemic oxaspiro PNN ligands can pass through the The spirocyclic diphenol is synthesized from the raw material. The PNN ligands of the present invention can be used as chiral ligands for asymmetric hydrogenation of ketones and lactones. Its complexes with iridium can yield enantioselectivities greater than 98% and 99% in the asymmetric hydrogenation of simple ketones and lactones, respectively.
priorityDate 2018-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104355997-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892672-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102040625-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422105170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471142
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457277700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33665
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96838
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415823800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415774943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415799999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415719525
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID634876
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1501874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131858137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447556054

Total number of triples: 52.